Literature DB >> 19898915

Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced age.

Matthias Kieslich1, Franziska Hoche, Janine Reichenbach, Stefan Weidauer, Luciana Porto, Stefan Vlaho, Ralf Schubert, Stefan Zielen.   

Abstract

Ataxia telangiectasia (AT) is a rare autosomal recessive disorder characterized by progressive ataxia, neurodegeneration, immunodeficiency, and cancer predisposition. Pathoanatomical studies reported a degeneration of cerebellar Purkinje cells as the striking feature of the disease. Although recent studies suggested the involvement of extracerebellar structures such as the brainstem and basal ganglia, this has rarely been studied in human AT. Thus, we performed a detailed cliniconeuroradiological investigation of 11 AT patients, aged 8 to 26 years by collecting clinical neurological data, ataxia scores, growth status, body mass index (BMI), growth hormone (GH), and insulin-like-growth factor 1 (IGF-1) and correlated them to extracerebellar neuroimaging findings in human AT. Neuroimaging was done by cranial and spine magnetic resonance imaging (MRI) with T1- and T2-weighted spin-echo and fluid attenuated inversion recovery sequences. We compared clinical and neuroradiological findings of six patients with IGF-1 levels and BMI below the third percentile to five patients with normal IGF-1 serum levels and BMI above the third percentile. Three of the six first mentioned patients older than 20 years and two patients older than 12 years showed noticeable high Klockgether ataxia scores above 25 points. Three of these patients presented with marked hyperintense lesions in the cerebral white matter of T2-weighted MR images. Interestingly, all six patients suffered from marked spinal atrophy. Two of the patients presented with severe extra-pyramidal symptoms, but only one patient showed associated MRI abnormalities of the basal ganglia. MRI in patients with normal IGF-1 levels showed the expected cerebellar lesions in four patients, whereas spinal atrophy was found only in two patients. There was no affection of the cerebral white matter or basal ganglia in this group. We conclude that central cerebral white matter affection, spinal atrophy, and extrapyramidal symptoms are more often present in patients with pronounced deficiency of the GH/IGF-1 axis accompanied by markedly reduced body weight and high ataxia scores. This may point to a major role of IGF-1 and nutritional status in neuroprotective signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19898915     DOI: 10.1007/s12311-009-0138-0

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  40 in total

1.  Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia.

Authors:  M A Lefton-Greif; T O Crawford; J A Winkelstein; G M Loughlin; C B Koerner; M Zahurak; H M Lederman
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

2.  Neuropathologic changes in ataxia-telangiectasia.

Authors:  G A De León; W D Grover; D S Huff
Journal:  Neurology       Date:  1976-10       Impact factor: 9.910

Review 3.  Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.

Authors:  R A Gatti; E Boder; H V Vinters; R S Sparkes; A Norman; K Lange
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

4.  Quantitative neurologic assessment of ataxia-telangiectasia.

Authors:  T O Crawford; A S Mandir; M A Lefton-Greif; S N Goodman; B K Goodman; H Sengul; H M Lederman
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

5.  Longitudinal evoked potential studies in hereditary ataxias.

Authors:  M J Taylor; W Y Chan-Lui; W J Logan
Journal:  Can J Neurol Sci       Date:  1985-05       Impact factor: 2.104

6.  Ataxia-telangiectasia: MR and CT findings.

Authors:  L Farina; C Uggetti; A Ottolini; A Martelli; R Bergamaschi; L Sibilla; F Zappoli; M G Egitto; G Lanzi
Journal:  J Comput Assist Tomogr       Date:  1994 Sep-Oct       Impact factor: 1.826

Review 7.  Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?

Authors:  G Rotman; Y Shiloh
Journal:  Bioessays       Date:  1997-10       Impact factor: 4.345

Review 8.  Ataxia-telangiectasia: an overview.

Authors:  E Boder
Journal:  Kroc Found Ser       Date:  1985

9.  Brain MRI abnormalities in ataxia-telangiectasia.

Authors:  Mario Habek; Vesna V Brinar; Marko Rados; Ivana Zadro; Kamelija Zarković
Journal:  Neurologist       Date:  2008-05       Impact factor: 1.398

10.  Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia.

Authors:  E O Chung; J B Bodensteiner; P A Noorani; S S Schochet
Journal:  J Child Neurol       Date:  1994-01       Impact factor: 1.987

View more
  13 in total

Review 1.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

2.  Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Authors:  R Saunders-Pullman; D Raymond; A J Stoessl; D Hobson; K Nakamura; T Nakamura; S Pullman; D Lefton; M S Okun; R Uitti; R Sachdev; K Stanley; M San Luciano; J Hagenah; R Gatti; L J Ozelius; S B Bressman
Journal:  Neurology       Date:  2012-02-15       Impact factor: 9.910

3.  Brain glucose metabolism in adults with ataxia-telangiectasia and their asymptomatic relatives.

Authors:  Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Yana Studentsova; Brad Margus; Thomas O Crawford
Journal:  Brain       Date:  2014-04-17       Impact factor: 13.501

Review 4.  Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Miles R Bryan; Aaron B Bowman
Journal:  Adv Neurobiol       Date:  2017

5.  Linear growth and endocrine function in children with ataxia telangiectasia.

Authors:  Mohammad Ehlayel; Ashraf Soliman; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2014-11

Review 6.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

7.  The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment.

Authors:  Jianmin Chen; Yanping Chen; Graham Vail; Heiman Chow; Yang Zhang; Lauren Louie; Jiali Li; Ronald P Hart; Mark R Plummer; Karl Herrup
Journal:  Mol Neurodegener       Date:  2016-08-18       Impact factor: 14.195

8.  Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study.

Authors:  H Pommerening; S van Dullemen; M Kieslich; R Schubert; S Zielen; S Voss
Journal:  Orphanet J Rare Dis       Date:  2015-12-09       Impact factor: 4.123

9.  Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.

Authors:  Sara Di Siena; Federica Campolo; Roberto Gimmelli; Chiara Di Pietro; Daniela Marazziti; Susanna Dolci; Andrea Lenzi; Andre Nussenzweig; Manuela Pellegrini
Journal:  Cell Death Dis       Date:  2018-02-22       Impact factor: 8.469

10.  Progressive Liver Disease in Patients With Ataxia Telangiectasia.

Authors:  Helena Donath; Sandra Woelke; Marius Theis; Ursula Heß; Viola Knop; Eva Herrmann; Dorothea Krauskopf; Matthias Kieslich; Ralf Schubert; Stefan Zielen
Journal:  Front Pediatr       Date:  2019-11-07       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.